| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |